Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 1631 entries
View as:

Expanded Access to Provide Copanlisib for Patients With Cancer Who Are Experiencing a Positive Response, as Determined by Their Doctors

Phase: N/A Priority: Normal
NCT ID: NCT06238583 Org: User:
Start: - End: - Due: -

Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A

Phase: N/A Priority: Normal
NCT ID: NCT03932201 Org: User:
Start: 10/21/19 End: 03/31/27 Due: 03/31/28

An Observational Study Called JOIHA to Learn More About How Well the Treatment With Jivi Works to Prevent Problems With Joints in Adults With Hemophilia A.

Phase: N/A Priority: Normal
NCT ID: NCT05643560 Org: User:
Start: 12/29/22 End: 06/30/27 Due: 06/30/28

Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT01810770 Org: User:
Start: 03/26/13 End: 09/25/17 Due: 09/25/18

Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)

Phase: N/A Priority: Normal
NCT ID: NCT02576002 Org: User:
Start: 10/31/15 End: 01/31/16 Due: 01/31/17

An Observational Study to Collect Information on the Safety of Gadolinium-Based Contrast Agents in Patients in India

Phase: N/A Priority: Normal
NCT ID: NCT06257277 Org: User:
Start: 07/08/24 End: 05/26/25 Due: 05/26/26

Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT01106118 Org: User:
Start: 01/31/10 End: 08/31/13 Due: 08/31/14

A Study to Assess the Efficacy and Safety of Vardenafil in the Treatment of Male Patients With Erectile Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT00654914 Org: User:
Start: 05/31/03 End: 02/29/04 Due: 02/28/05

A Study to Assess Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids

Phase: N/A Priority: Normal
NCT ID: NCT03240523 Org: User:
Start: 07/31/17 End: 10/25/21 Due: 10/25/22

Mirena Observational Program

Phase: N/A Priority: Normal
NCT ID: NCT00883662 Org: User:
Start: 05/31/09 End: 11/30/15 Due: 11/30/16

Cycle Control and Safety of E2-DRSP

Phase: N/A Priority: Normal
NCT ID: NCT00653614 Org: User:
Start: 03/31/08 End: 06/30/09 Due: 06/30/10

Safety and Efficacy of Gadobutrol 1.0 Molar in Japanese Subjects for CNS Imaging

Phase: N/A Priority: Normal
NCT ID: NCT01660841 Org: User:
Start: 09/30/12 End: 08/31/13 Due: 08/31/14

Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif

Phase: N/A Priority: Normal
NCT ID: NCT00317941 Org: User:
Start: 03/31/06 End: 04/30/08 Due: 04/30/09

Study of Nexavar (Sorafenib, BAY 43-9006) in Patients With Advanced Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00079612 Org: User:
Start: 09/30/02 End: 01/31/07 Due: 01/31/08

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00624130 Org: User:
Start: 03/31/04 End: 06/30/05 Due: 06/30/06

Betaferon® Regulatory Post-Marketing Surveillance

Phase: N/A Priority: Normal
NCT ID: NCT01414816 Org: User:
Start: 04/30/08 End: 07/31/12 Due: 07/31/13

Bioequivalence Trial to Prove Equal Blood Concentrations of Two Different Fluconazole Formulations

Phase: N/A Priority: Normal
NCT ID: NCT03929861 Org: User:
Start: 07/31/12 End: 09/10/12 Due: 09/10/13

A Trial to Compare the Duration of Analgesic Efficacy and Safety of Naproxen Sodium Tablets and Ibuprofen Tablets in Postsurgical Dental Pain

Phase: N/A Priority: Normal
NCT ID: NCT03404206 Org: User:
Start: 02/12/18 End: 07/10/18 Due: 07/10/19

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

Phase: N/A Priority: Normal
NCT ID: NCT02289924 Org: User:
Start: 01/09/15 End: 07/08/19 Due: 07/08/20

Nexavar Post-marketing Surveillance for RCC in Japan: Early Access Program

Phase: N/A Priority: Normal
NCT ID: NCT01412671 Org: User:
Start: 02/27/08 End: 02/28/16 Due: 02/28/17

Regorafenib Eye Drops: Investigation of Efficacy and Safety in Neovascular Age Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT02222207 Org: User:
Start: 10/31/14 End: 06/30/15 Due: 06/30/16

Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04265781 Org: User:
Start: 02/15/20 End: 09/20/20 Due: 09/20/21

Supervised Outdoor-Use Test to Assess the Safety of a Sunscreen C-Spray on Sport Users

Phase: N/A Priority: Normal
NCT ID: NCT02857478 Org: User:
Start: 06/27/15 End: 06/28/15 Due: 06/28/16

Study to Learn More About the Effect of a New Drug Called BAY2327949 on the Blood Flow Through Kidneys in Adult Participants With Moderate Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT04552262 Org: User:
Start: 09/30/20 End: 05/05/21 Due: 05/05/22

Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone

Phase: N/A Priority: Normal
NCT ID: NCT03484260 Org: User:
Start: 04/01/18 End: 05/15/18 Due: 05/15/19